| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5632984 | Pediatric Neurology | 2017 | 15 Pages |
Abstract
Despite the known safety profile of glatiramer acetate in adult and pediatric patients with multiple sclerosis, its use in Rett syndrome should be cautiously reconsidered. The described severe adverse event can be related to these patients' primary autonomic nervous system dysfunction.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Andreea MD, Mona MD, Bruria MD,